No association of VEGF polymorphims with alzheimer's disease

NeuroMolecular Medicine

Volumn 12, Issue 3, 2010, Pages 224-228

  Landgren, Sara ^d   Palmér, Mona Seibt ^a   Skoog, Ingemar ^a   Minthon, Lennart ^b   Wallin, Anders ^a   Andreasen, Niels ^c   Zetterberg, Madeleine ^a   Blennow, Kaj ^a   Zetterberg, Henrik ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d NONE

Author keywords

Amyloid; Alzheimer's disease; Tau; VEGF

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; BIOLOGICAL MARKER; TAU PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENILE PLAQUE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78649921495     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12017-009-8096-8     Document Type: Article

References (24)

1. Altman, D. G. (1991). Practical statistics for medical research (1st ed.). London: Chapman & Hall.
2. Blacker, D., Bertram, L., Saunders, A. J., Moscarillo, T. J., Albert, M. S., Wiener, H., et al. (2003). Results of a high-resolution genome screen of 437 Alzheimer's disease families. Human Molecular Genetics, 12, 23-32.
3. Blennow, K., Ricksten, A., Prince, J. A., Brookes, A. J., Emahazion, T., Wasslavik, C., et al. (2000). No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression. Journal of Neural Transmission, 107, 1065-1079.
4. Borroni, B., Ghezzi, S., Agosti, C., Archetti, S., Fenoglio, C., Galimberti, D., et al. (2008). Preliminary evidence that VEGF genetic variability confers susceptibility to frontotemporal lobar degeneration. Rejuvenation Research, 11, 773-780.
5. Cao, L., Jiao, X., Zuzga, D. S., Liu, Y., Fong, D. M., Young, D., et al. (2004). VEGF links hippocampal activity with neurogenesis, learning and memory. Nature Genetics, 36, 827-835.
6. Casserly, I., & Topol, E. (2004). Convergence of atherosclerosis and Alzheimer's disease: Inflammation, cholesterol, and misfolded proteins. Lancet, 363, 1139-1146.
7. Chapuis, J., Tian, J., Shi, J., Bensemain, F., Cottel, D., Lendon, C., et al. (2006). Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer's disease. Neurobiology of Aging, 27, 1212-1215.
8. Chiappelli, M., Borroni, B., Archetti, S., Calabrese, E., Corsi, M. M., Franceschi, M., et al. (2006). VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment. Rejuvenation Research, 9, 485-493.
9. Del Bo, R., Scarlato, M., Ghezzi, S., Martinelli Boneschi, F., Fenoglio, C., Galbiati, S., et al. (2005). Vascular endothelial growth factor gene variability is associated with increased risk for AD. Annals of Neurology, 57, 373-380.
10. Farkas, E., & Luiten, P. G. (2001). Cerebral microvascular pathology in aging and Alzheimer's disease. Progress in Neurobiology, 64, 575-611.
11. Hulstaert, F., Blennow, K., Ivanoiu, A., Schoonderwaldt, H. C., Riemenschneider, M., De Deyn, P. P., et al. (1999). Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. Neurology, 52, 1555-1562.
12. Johansson, A., Katzov, H., Zetterberg, H., Feuk, L., Johansson, B., Bogdanovic, N., et al. (2004). Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease. Human Genetics, 114, 581-587.
13. Kalaria, R. N., Cohen, D. L., Premkumar, D. R., Nag, S., LaManna, J. C., & Lust, W. D. (1998). Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Brain Research. Molecular Brain Research, 62, 101-105.
14. Kim, Y., Nam, Y. J., & Lee, C. (2006). Haplotype analysis of single nucleotide polymorphisms in VEGF gene for vascular dementia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 141B, 332-335.
15. Livak, K. J. (1999). Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genetic Analysis, 14, 143-149.
16. Mateo, I., Llorca, J., Infante, J., Rodriguez-Rodriguez, E., Fernandez-Viadero, C., Pena, N., et al. (2007). Low serum VEGF levels are associated with Alzheimer's disease. Acta Neurologica Scandinavica, 116, 56-58. (Pubitemid 46976267)
17. Mateo, I., Llorca, J., Infante, J., Rodriguez-Rodriguez, E., Sanchez-Quintana, C., Sanchez-Juan, P., et al. (2006). Case-control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer's disease. Neuroscience Letters, 401, 171-173.
18. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939-944.
19. Stevens, A., Soden, J., Brenchley, P. E., Ralph, S., & Ray, D. W. (2003). Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Research, 63, 812-816.
20. Storkebaum, E., & Carmeliet, P. (2004). VEGF: A critical player in neurodegeneration. Journal of Clinical Investigation, 113, 14-18.
21. Vanmechelen, E., Vanderstichele, H., Davidsson, P., Van Kerschaver, E., Van Der Perre, B., Sjogren, M., et al. (2000). Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: A sandwich ELISA with a synthetic phosphopeptide for standardization. Neuroscience Letters, 285, 49-52.
22. Yang, S. P., Bae, D. G., Kang, H. J., Gwag, B. J., Gho, Y. S., & Chae, C. B. (2004). Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease. Neurobiology of Aging, 25, 283-290.
23. Yuan, Q., Zuo, X., & Jia, J. (2009). Association between promoter polymorphisms of vascular endothelial growth factor gene and sporadic Alzheimer's disease among Northern Chinese Han. Neuroscience Letters, 457, 133-136.
24. Zetterberg, H. (2008). Biomarkers reflecting different facets of Alzheimer's disease. European Journal of Neurology, 15, 1143-1144.